WEDNESDAY, June 25, 2025 (HealthDay News) — For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene zamikeracel, an autologous COL7A1 gene-modified cellular sheet that is […]
The post Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa first appeared on Blackandmed .
